$MDGL
Madrigal Pharmaceuticals, Inc.
$480.77
+6.49
(+1.37%)
Today
A volume-weighted average price line from the last reported earnings date through today.
About Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
- CEO
- Mr. William J. Sibold
- Employees
- 915
- Headquarters
- West Conshohocken, PA
- Sector
- Healthcare
- Industry
- Biotechnology
- Website
- madrigalpharma.com
Key stats
- Market Cap
- $11.08B
- P/E Ratio
- —
- Avg Volume (3M)
- 312.46K
- EPS
- $-13.51
- Day's Range
- $469.07 – $486.10
Fundamentals as of Jun 15, 2026